Medilink West Midlands' Sue Wilde-Greer discusses the evidence gathered for the Innovation Health & Wealth, Accelerating Adoption & Diffusion in the NHS Report
As the Life Science industry continues to develop, should the UK be investing in the growth of life sciences for our future or should we be investing in our existing manufacturing and service base enabling it to grow?
By Michael Gill, Chief Executive of Medilink North West
As the Life Science industry continues to develop, should the UK be investing in the growth of life sciences for our future or should we be investing in our existing manufacturing and service base enabling it to grow?
Tackling current issues faced by the medical and healthcare industry, our experts are here to help. Want to add a comment? Click here.